CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." ...
CVS Health has named Ed DeVaney president of the company's CVS Caremark pharmacy benefits manager business, CVS announced this week. DeVaney ascends to the top post after having been named interim ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...
Blue Trust Inc. decreased its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 14.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm ...
CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...
With retail space in scarce supply, it has not been difficult to entice new tenants to small spaces like Medical Arts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results